Durham, NC (PRWEB) October 06, 2014
Clinverse, Inc., provider of automated financial management technology solutions for clinical trials, announced it will be exhibiting and showcasing its automated investigator payment solutions at booth #31 at Site Solutions Summit in Amelia Island, Fla., Oct. 10-12, 2014.
Clinverse recently closed a $9.1 million Series C round of funding, which will be used to accelerate development of the product roadmap, internal infrastructure, and sales and marketing plans in response to the growing demand for its automated solutions. Clinverse’s flagship product, ClinPay®, is designed to automate the financial management of global clinical trials from the initial site contract to the payment of investigative sites. ClinPay also manages GAAP accounting and provides in-depth reporting and transparency throughout the life of the trial.
In addition to exhibiting, Steve Ayala, President and Co-Founder of Clinverse, will be a panelist in a Learning Lab on Oct. 11 at 3:15pm. Along with two other panelists, he will lead a discussion entitled “Fair Market Value - What is it, How is it determined, & How do I negotiate around it?”.
To schedule a time to meet with a Clinverse team member while at Site Solutions Summit 2014 to learn more about our suite of clinical trial financial management solutions, please contact us at 1.877.325.1122 or info(at)clinverse(dot)com.
About Clinverse, Inc.
Clinverse, Inc. architected the industry’s first automated financial management technology solutions for clinical trials. Powered by our secure technology platform, our solution standardizes clinical trial finance and manages millions of financial transactions across the globe, including clinical site payments. Used by leading BioPharma companies, our clients benefit from reduced workload, time, and costs gained through automation and unprecedented transparency and workflow. For more information, please visit http://www.clinverse.com.